Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against Staphylococcus aureus
- PMID: 34486341
- DOI: 10.3923/pjbs.2021.656.662
Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against Staphylococcus aureus
Abstract
<b>Background and Objective:</b> Antibacterial resistance is one of the top global public health problems. The use of natural substances, which can enhance the antibacterial activity of currently used medications, is a promising alternative to oppose antibacterial resistance. The pharmacological activities of lupinifolin, a prenylated flavanone isolated from stems of <i>Derris reticulata</i> Craib., against growth and biofilm formation of <i>Streptococcus mutans</i> and <i>Staphylococcus aureus</i> have been previously documented. Nonetheless, interactions between lupinifolin and other antibacterial agents have not been determined. This study aimed to investigate the effects of lupinifolin in combinations with some antibacterial agents, specifically ampicillin, cloxacillin or vancomycin, against <i>S. mutans</i>, Methicillin-Sensitive <i>S. aureus</i> (MSSA) and Methicillin-Resistant <i>S. aureus</i> (MRSA). <b>Materials and Methods:</b> The checkerboard assay was performed to determine the antibacterial activity of lupinifolin plus the testing antibacterial agents. The Fractional Inhibitory Concentration Index (FICI) was calculated to indicate the interaction between lupinifolin and the antibacterial agent tested. <b>Results:</b> Lupinifolin exerted the synergistic activity when using in combination with ampicillin or cloxacillin against MSSA with the FICIs of <u><</u>0.5. The potential synergistic effect was also observed with lupinifolin plus ampicillin or cloxacillin against MRSA. However, the combination of lupinifolin plus vancomycin resulted in no interaction against MRSA. The combined effects of lupinifolin and ampicillin or cloxacillin against <i>S. mutans</i> were somewhat ambiguous with the borderline values of FICI of 0.5156 and 0.5625, respectively. <b>Conclusion:</b> Lupinifolin potentially plays a role as an antibacterial intensifier against some pathogenic gram-positive bacteria, particularly MSSA and MRSA. Nonetheless, further experiments are required to explain the precise mechanism of synergy.
Keywords: Lupinifolin; Streptococcus mutans; antibacterial intensifier; methicillin-resistant Staphylococcus aureus; methicillin-sensitive Staphylococcus aureus; synergistic effect.
Similar articles
-
Antibiofilm Formation Activity of Lupinifolin Against Methicillin-Resistant Staphylococcus aureus.Pak J Biol Sci. 2022 Jan;25(11):961-970. doi: 10.3923/pjbs.2022.961.970. Pak J Biol Sci. 2022. PMID: 36591926
-
Herbal Products and Their Active Constituents Used Alone and in Combination with Antibiotics against Multidrug-Resistant Bacteria.Planta Med. 2023 Feb;89(2):168-182. doi: 10.1055/a-1890-5559. Epub 2022 Aug 22. Planta Med. 2023. PMID: 35995069 Review.
-
Phytochemicals with activity against methicillin-resistant Staphylococcus aureus.Phytomedicine. 2022 Jun;100:154073. doi: 10.1016/j.phymed.2022.154073. Epub 2022 Apr 1. Phytomedicine. 2022. PMID: 35397285 Review.
-
Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates.Phytomedicine. 2018 Jan 15;39:93-99. doi: 10.1016/j.phymed.2017.12.023. Epub 2017 Dec 21. Phytomedicine. 2018. PMID: 29433688
-
Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.J Glob Antimicrob Resist. 2017 Sep;10:70-74. doi: 10.1016/j.jgar.2017.03.012. Epub 2017 Jun 30. J Glob Antimicrob Resist. 2017. PMID: 28673701
Cited by
-
Antimycobacterial Precatorin A Flavonoid Displays Antibiofilm Activity against Mycobacterium bovis BCG.ACS Omega. 2023 Oct 20;8(43):40665-40676. doi: 10.1021/acsomega.3c05703. eCollection 2023 Oct 31. ACS Omega. 2023. PMID: 37929145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous